Highnoon Labs’ profit jumps 22%, declares 500% dividend
07-Apr-2026
MettisGlobal
April 7, 2026 (MLN): Highnoon Laboratories Limited (PSX: HINOON) posted a robust net profit of Rs4.13 billion for the year ended 2025, up 21.83% from Rs3.39bn recorded in 2024.
The company’s earnings per share (EPS) also rose sharply to
Rs77.92 from Rs63.95 in the corresponding period last year.
The strong performance was driven by a 12.44% increase in
revenue from contracts with customers, which rose to Rs27.71 billion from
Rs24.64bn in 2024.
Gross profit surged 21.31% to Rs15.20bn, supported by only a
moderate 3.26% rise in the cost of revenue to Rs12.51bn.
Operational expenses rose across the board, with
distribution, selling, and promotional expenses increasing 17.14% to Rs7.10bn,
while administrative and general expenses climbed 30.44% to Rs1.21bn.
Research and development outlays edged up 13.97% to Rs10.79m,
and other operating expenses grew 9.57% to Rs583.49m. Despite these higher
expenditures, profit from operations expanded 25.92% to Rs6.29bn, up from Rs5.00bn
last year.
Other income remained largely stable at Rs441.0m, virtually
unchanged from the prior year. Finance costs fell sharply by 67.87% to Rs130.91m,
providing additional support to the bottom line.
After accounting for minor levies of Rs13.23m and a higher
taxation charge of Rs2.46bn (up 51.62% YoY), the company finalized its net
profit at Rs4.13bn for the year.
Showing its strong financial performance, Highnoon
Laboratories declared a cash dividend of 500%, rewarding shareholders with a
substantial return.
|
STATEMENT OF PROFIT OR
LOSS FOR THE YEAR ENDED DECEMBER 31, 2025 (Rs.) |
|||
|
Description |
2025 |
2024 |
Change
(%) |
|
Revenue
from contracts with customers |
27,705,637,954 |
24,640,892,959 |
12.44% |
|
Cost
of Revenue |
(12,507,003,884) |
(12,111,880,293) |
3.26% |
|
Gross
Profit |
15,198,634,070 |
12,529,012,666 |
21.31% |
|
Distribution,
selling and promotional expenses |
(7,097,071,133) |
(6,058,394,373) |
17.14% |
|
Administrative
and general expenses |
(1,213,403,604) |
(930,223,552) |
30.44% |
|
Research
and development expenses |
(10,793,866) |
(9,470,982) |
13.97% |
|
Other
operating expenses |
(583,491,230) |
(532,549,199) |
9.57% |
|
Profit
from operations |
6,293,874,237 |
4,998,374,560 |
25.92% |
|
Other
income |
440,979,971 |
441,506,392 |
-0.12% |
|
Finance
cost |
(130,906,685) |
(407,381,214) |
-67.87% |
|
Profit
before income tax and levy |
6,603,947,523 |
5,032,499,738 |
31.23% |
|
Levy |
(13,232,674) |
(19,930,608) |
-33.61% |
|
Profit
before income tax |
6,590,714,849 |
5,012,569,130 |
31.48% |
|
Taxation |
(2,462,397,447) |
(1,624,053,116) |
51.62% |
|
Profit
for the year |
4,128,317,402 |
3,388,516,014 |
21.83% |
|
Earnings
per share - basic and diluted |
77.92 |
63.95 |
21.85% |
Copyright